Nuclear Medicine: Page 46

Firm nabs $1.4M for prostate cancer drug

By AuntMinnie.com staff writers

The U.S. National Institutes of Health has awarded biotechnology firm Cancer Targeted Technology $1.4 million in the second year of a grant to fund development of a radiotherapeutic prostate cancer drug.

August 6, 2020

SRI gets funding to research radiation relief

By AuntMinnie.com staff writers

R&D institute SRI International has a received contract worth up to $100 million to develop technologies for treating excessive radiation exposure.

August 4, 2020

U.S. government awards SNMMI $750K grant

By AuntMinnie.com staff writers

The U.S. Department of Energy's National Nuclear Security Administration (NNSA) awarded the Society of Nuclear Medicine and Molecular Imaging (SNMMI) a grant for $750,000 over three years to support nuclear medicine initiatives in sub-Saharan Africa.

July 30, 2020

Lantheus revenue plummets 23% in Q2

By AuntMinnie.com staff writers

The parent company of Lantheus Medical Imaging posted a significant drop in revenue and swung to a net loss for the second quarter of 2020 due to the COVID-19 pandemic.

July 29, 2020

Clarity begins trial for pediatric neuroblastoma therapy

By AuntMinnie.com staff writers

Radiopharmaceutical firm Clarity Pharmaceuticals has begun recruitment for a phase I/IIA clinical trial evaluating its SARTATE peptide receptor radionuclide therapy for pediatric patients with neuroblastoma.

July 22, 2020

Clarity, ImaginAb team to develop theranostic agents

By AuntMinnie.com staff writers

Radiopharmaceutical firm Clarity Pharmaceuticals and imaging agent developer ImaginAb are collaborating to develop new targeted theranostic products for a range of cancer types.

July 20, 2020

SNMMI 2020: PSMA-PET/CT changes prostate cancer management

By Kate Madden Yee

PET/CT imaging with an F-18 DCFPyL prostate-specific membrane antigen (PSMA) radiopharmaceutical changed prostate cancer management in two-thirds of cases, according to research presented July 13 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.

July 14, 2020

SNMMI 2020: AI can aid in diagnosis of Parkinson's disease

By Erik L. Ridley

An artificial intelligence (AI) algorithm was highly accurate for diagnosing Parkinson's disease on dopamine transporter SPECT exams, according to research presented at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

July 13, 2020

SNMMI taps leaders for 2020-2021 year

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has tapped its leadership slate for the 2020-2021 year at this week's virtual conference.

July 13, 2020

SNMMI 2020: How nuclear medicine handled COVID-19

By Wayne Forrest

Implementing a proactive, multipronged strategy to combat the COVID-19 pandemic helped Mount Sinai Hospital safeguard its patients and staff as much as humanly possible, according to a Monday presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 virtual annual meeting.

July 13, 2020

SNMMI 2020: Medical students key to the specialty's future

By Wayne Forrest

The early recruitment of medical students into nuclear medicine and molecular imaging is the key to the specialty's future, said Dr. Vasken Dilsizian during his president's address on Sunday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) virtual annual meeting.

July 12, 2020

Spectrum Dynamics debuts new cardiac SPECT system

By AuntMinnie.com staff writers

Molecular imaging technology developer Spectrum Dynamics Medical has introduced D-SPECT Vista, a digital solid-state cadmium zinc telluride-based cardiac SPECT system.

July 9, 2020

Previous Page

Page 46 of 440

Next Page